CompuMed Inc
CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpreta… Read more
CompuMed Inc (CMPD) - Net Assets
Latest net assets as of December 2025: $3.08 Million USD
Based on the latest financial reports, CompuMed Inc (CMPD) has net assets worth $3.08 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.69 Million) and total liabilities ($1.61 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.08 Million |
| % of Total Assets | 65.7% |
| Annual Growth Rate | 0.5% |
| 5-Year Change | -7.77% |
| 10-Year Change | 874.87% |
| Growth Volatility | 71.83 |
CompuMed Inc - Net Assets Trend (1990–2025)
This chart illustrates how CompuMed Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CompuMed Inc (1990–2025)
The table below shows the annual net assets of CompuMed Inc from 1990 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $3.10 Million | -5.63% |
| 2024-09-30 | $3.28 Million | +6.23% |
| 2023-09-30 | $3.09 Million | -19.67% |
| 2022-09-30 | $3.85 Million | +14.52% |
| 2021-09-30 | $3.36 Million | +47.47% |
| 2020-09-30 | $2.28 Million | +23.17% |
| 2019-09-30 | $1.85 Million | +126.95% |
| 2018-09-30 | $815.33K | +89.10% |
| 2017-09-30 | $431.16K | +35.60% |
| 2016-09-30 | $317.95K | +3.86% |
| 2015-09-30 | $306.13K | +163.90% |
| 2011-09-30 | $116.00K | -65.06% |
| 2010-09-30 | $332.00K | -40.29% |
| 2009-09-30 | $556.00K | -22.02% |
| 2008-09-30 | $713.00K | -56.52% |
| 2007-09-30 | $1.64 Million | +98.07% |
| 2006-09-30 | $828.00K | +2.60% |
| 2005-09-30 | $807.00K | +55.79% |
| 2004-09-30 | $518.00K | +1.77% |
| 2003-09-30 | $509.00K | -37.70% |
| 2002-09-30 | $817.00K | -39.44% |
| 2001-09-30 | $1.35 Million | -40.04% |
| 2000-09-30 | $2.25 Million | -22.41% |
| 1999-09-30 | $2.90 Million | +3.57% |
| 1998-09-30 | $2.80 Million | +211.11% |
| 1997-09-30 | $900.00K | -70.00% |
| 1996-09-30 | $3.00 Million | -42.31% |
| 1995-09-30 | $5.20 Million | +173.68% |
| 1994-09-30 | $1.90 Million | +90.00% |
| 1993-09-30 | $1.00 Million | -64.29% |
| 1992-09-30 | $2.80 Million | -15.15% |
| 1991-09-30 | $3.30 Million | +26.92% |
| 1990-09-30 | $2.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CompuMed Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2665524900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $416.93K | 13.45% |
| Other Components | $36.64 Million | 1182.01% |
| Total Equity | $3.10 Million | 100.00% |
CompuMed Inc Competitors by Market Cap
The table below lists competitors of CompuMed Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Darkpulse Inc
PINK:DPLS
|
$33.45K |
|
ERCROS (CRS1.SG)
STU:CRS1
|
$33.53K |
|
BG CHINA GROWTH TR.LS-25
F:WJ1
|
$33.53K |
|
POLYTEC HOLDING
MU:P4N
|
$33.54K |
|
Apolo IV Acquisition Corp
V:AIV-P
|
$33.42K |
|
APRANGA (WHX.SG)
STU:WHX
|
$33.40K |
|
Zhejiang Huayuan Auto Technology Co., Ltd.
SHE:301535
|
$33.39K |
|
HUSQVARNA -B- - Dusseldorf Stock Exchang
DU:HRZ
|
$33.38K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CompuMed Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,284,563 to 3,099,642, a change of -184,921 (-5.6%).
- Net loss of 64,227 reduced equity.
- Share repurchases of 130,695 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-64.23K | -2.07% |
| Share Repurchases | $130.69K | -4.22% |
| Other Changes | $10.00K | +0.32% |
| Total Change | $- | -5.63% |
Book Value vs Market Value Analysis
This analysis compares CompuMed Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.53x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.06x to 1.53x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1990-09-30 | $65.00 | $3.60 | x |
| 1991-09-30 | $49.50 | $3.60 | x |
| 1992-09-30 | $40.00 | $3.60 | x |
| 1993-09-30 | $7.95 | $3.60 | x |
| 1994-09-30 | $10.96 | $3.60 | x |
| 1995-09-30 | $21.14 | $3.60 | x |
| 1996-09-30 | $8.80 | $3.60 | x |
| 1997-09-30 | $2.56 | $3.60 | x |
| 1998-09-30 | $11.67 | $3.60 | x |
| 1999-09-30 | $4.61 | $3.60 | x |
| 2000-09-30 | $3.25 | $3.60 | x |
| 2001-09-30 | $1.89 | $3.60 | x |
| 2002-09-30 | $1.14 | $3.60 | x |
| 2003-09-30 | $0.71 | $3.60 | x |
| 2004-09-30 | $0.71 | $3.60 | x |
| 2005-09-30 | $0.96 | $3.60 | x |
| 2006-09-30 | $0.87 | $3.60 | x |
| 2007-09-30 | $1.67 | $3.60 | x |
| 2008-09-30 | $0.70 | $3.60 | x |
| 2009-09-30 | $0.54 | $3.60 | x |
| 2010-09-30 | $0.31 | $3.60 | x |
| 2011-09-30 | $0.10 | $3.60 | x |
| 2016-09-30 | $0.25 | $3.60 | x |
| 2017-09-30 | $0.34 | $3.60 | x |
| 2018-09-30 | $0.64 | $3.60 | x |
| 2019-09-30 | $1.43 | $3.60 | x |
| 2020-09-30 | $1.77 | $3.60 | x |
| 2021-09-30 | $2.19 | $3.60 | x |
| 2022-09-30 | $2.30 | $3.60 | x |
| 2023-09-30 | $1.98 | $3.60 | x |
| 2024-09-30 | $2.49 | $3.60 | x |
| 2025-09-30 | $2.35 | $3.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CompuMed Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.85%
- • Asset Turnover: 1.51x
- • Equity Multiplier: 1.62x
- Recent ROE (-2.07%) is above the historical average (-58.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1990 | -3.85% | -2.56% | 1.05x | 1.42x | $-360.00K |
| 1991 | -15.15% | -12.82% | 0.85x | 1.39x | $-830.00K |
| 1992 | -71.43% | -60.61% | 0.87x | 1.36x | $-2.28 Million |
| 1993 | -220.00% | -73.33% | 1.30x | 2.30x | $-2.30 Million |
| 1994 | -205.26% | -162.50% | 0.35x | 3.63x | $-4.09 Million |
| 1995 | -65.38% | -113.33% | 0.29x | 2.02x | $-3.92 Million |
| 1996 | -153.33% | -176.92% | 0.65x | 1.33x | $-4.90 Million |
| 1997 | -244.44% | -115.79% | 1.06x | 2.00x | $-2.29 Million |
| 1998 | -46.43% | -72.22% | 0.51x | 1.25x | $-1.58 Million |
| 1999 | -37.93% | -47.83% | 0.61x | 1.31x | $-1.39 Million |
| 2000 | -64.22% | -75.54% | 0.61x | 1.39x | $-1.67 Million |
| 2001 | -66.49% | -46.55% | 1.15x | 1.24x | $-1.03 Million |
| 2002 | -60.47% | -25.27% | 1.83x | 1.31x | $-575.70K |
| 2003 | -73.67% | -20.71% | 2.32x | 1.53x | $-425.90K |
| 2004 | -53.09% | -14.82% | 2.28x | 1.57x | $-326.80K |
| 2005 | -41.64% | -14.71% | 1.79x | 1.58x | $-416.70K |
| 2006 | -51.21% | -20.06% | 1.76x | 1.45x | $-506.80K |
| 2007 | -105.79% | -78.29% | 0.98x | 1.38x | $-1.90 Million |
| 2008 | -217.11% | -71.90% | 1.64x | 1.84x | $-1.62 Million |
| 2009 | -45.86% | -12.45% | 2.03x | 1.81x | $-310.60K |
| 2010 | -113.86% | -21.45% | 2.38x | 2.23x | $-411.20K |
| 2011 | -102.59% | -7.08% | 2.82x | 5.14x | $-130.60K |
| 2015 | 24.12% | 3.26% | 2.49x | 2.97x | $43.21K |
| 2016 | -42.28% | -6.39% | 3.38x | 1.96x | $-166.22K |
| 2017 | 19.70% | 3.68% | 2.76x | 1.94x | $41.83K |
| 2018 | 26.91% | 6.23% | 2.32x | 1.86x | $137.91K |
| 2019 | 52.63% | 19.29% | 1.74x | 1.57x | $788.75K |
| 2020 | 14.85% | 6.42% | 1.28x | 1.80x | $110.53K |
| 2021 | 31.75% | 16.89% | 1.23x | 1.53x | $731.06K |
| 2022 | 13.04% | 7.88% | 1.19x | 1.39x | $116.97K |
| 2023 | -1.05% | -0.56% | 1.32x | 1.44x | $-341.79K |
| 2024 | 5.87% | 3.10% | 1.35x | 1.41x | $-135.80K |
| 2025 | -2.07% | -0.85% | 1.51x | 1.62x | $-374.19K |
Industry Comparison
This section compares CompuMed Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CompuMed Inc (CMPD) | $3.08 Million | -3.85% | 0.52x | $33.43K |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |